Tscan Therapeutics, Inc. (TCRX) SEC Filings — 2024
27 SEC filings for Tscan Therapeutics, Inc. (TCRX) in 2024.
Filings
- TScan Therapeutics Merges with Enliven Therapeutics, Renames Company — 8-K · Dec 26, 2024
- TScan Therapeutics Terminates Agreement, Incurs Obligation — 8-K · Dec 23, 2024
- Enovis to Acquire TScan Therapeutics for $1.1B — 8-K · Dec 10, 2024
- TScan Therapeutics Reports Unregistered Equity Sale — 8-K · Nov 21, 2024
- Tscan Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Tscan Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Tscan Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- TScan Therapeutics Q3 2024 Update — 10-Q · Nov 12, 2024
- Tscan Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 8, 2024
- TScan Therapeutics Enters Material Definitive Agreement — 8-K · Nov 1, 2024
- Tscan Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 21, 2024
- TScan Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 12, 2024
- Armata to Acquire TScan Therapeutics for $1.1B — 8-K · Jun 14, 2024
- TScan Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
- TScan Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders on June 12, 2024 — DEF 14A · Apr 30, 2024
- Tscan Therapeutics, Inc. SC 13G Filing — SC 13G · Apr 29, 2024
- Baker Bros. Advisors Amends TScan Therapeutics Stake — SC 13D/A · Apr 23, 2024
- TScan Therapeutics Enters Material Agreement — 8-K · Apr 17, 2024
- TScan Therapeutics Files 8-K Report — 8-K · Apr 16, 2024
- TScan Therapeutics Files Amendment to Annual Report — 10-K/A · Apr 10, 2024
- TScan Therapeutics Files 8-K — 8-K · Apr 8, 2024
- TScan Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 6, 2024
- Tscan Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- GV 2017, L.P. Updates Passive Stake in TScan Therapeutics — SC 13G/A · Feb 9, 2024
- Pitango HealthTech Fund I Updates Passive Stake in TScan Therapeutics — SC 13G/A · Feb 8, 2024
- Adage Capital Slashes TScan Therapeutics Stake to Just 3 Shares — SC 13G/A · Feb 7, 2024
- TScan Therapeutics Names Gavin MacBeath CEO; David Southwell Becomes Executive Chair — 8-K · Jan 29, 2024